EHMSG 2020 Virtual Conference | Live Sessions
PROGRAMME
SATURDAY, SEPTEMBER 12, 2020
08.30 – 08.50 I - Introductory Lecture
A tribute to George Sachs: pH & Hp revisited, then and now
Richard Hunt, Hamilton, ON, Canada
08.50 – 09.50 II - Gastric Epithelium Homeostasis in Health and Disease
08.50 – 09.10 Unexpected role of TLR5: Flagellin-independent but T4SS-dependent activation controls
Helicobacter pylori infections
Steffen Backert, Erlangen, Germany
09.10 – 09.30 Molecular mechanisms in epithelial barrier integrity
Ceu Figueiredo, Porto, Portugal
09.30 09.50 Gastric organoids as a tool to study Helicobacter infection
Francesco Boccellato, Oxford, UK
09.50 – 10.00 10 minutes break
10.00 – 12.30 III - Symposium: H. pylori diagnostics & treatment
10.00 – 10.20 “Test and Treat” strategy with UBT: a cost effective strategy for the management of H. pylori
infection in UK
Mark Pritchard, Liverpool, UK
10.20 – 10.40 Rationale behind UBT H. pylori screening and eradication therapy to reduce the risk of Upper GI
bleeding in patients with myocardial Infarction. Insights from the HELP-PILOT study
Magnus Bäck, Stockholm, Sweden
10.40 – 11.00 Acid suppression – how much is needed?
Takahisa Furuta, Hamamatsu, Japan
11.00 – 11.20 Renaissance reviewed - Bismuth still needed?
Peter Malfertheiner, Magdeburg, Germany
11.20 – 11.30 10 minutes break
11.30 – 11.50 Overcoming antibiotic resistance – the Korean experience
Ji Yong Ahn, Ulsan, Korea
11.50 – 12.10 Guidelines are good – adherence is better
Pali Hungin, Durham, UK
12.10 – 12.30 Management of H. pylori infection based on global/regional guidelines
Seung Joo Kang, Seoul, Korea
12.30 – 12.35 IV - Presentation of the Journal "Microbiota in Health and Disease"
Francesco Franceschi, Rome, Italy
12.35 – 12.40 V - Awarding of the Marshall & Warren Medal to Hazel Mitchell, Australia
Hazel Mitchell, Sydney, Australia
12.40 – 13.40 Lunch break
13.40 – 14.40 VI - Sponsored Symposium
14.40 – 15.40 VII - Gut Microbiota in Health and Disease
14.40 – 15.00 Microbial Therapeutics: Are we there yet? Clinicians perspective
Tariq Iqbal, Birmingham, UK
15.00 – 15.20 Using the microbiome to turn liquid diet into solid food. The CD-TREAT diet for treating Crohn’s
disease
Richard Hansen, Glasgow, UK
15.20 – 15.40 Microbial transplant – what are the challenges?
Josbert Keller, Leiden, The Netherlands
15.40 – 15.50 10 minutes break
15.50 – 16.50 VIII - EHMSG Guidelines initiative in microbiota handling
15.50 – 16.10 The challenge of microbiota testing
Antonio Gasbarrini, Rome, Italy
16.10 – 16.30 Requirements for optimal testing
Mirjana Rajilic-Stojanovic, Belgrade, Serbia
16.30 – 16.50 Clinical relevance of microbiota signature
Gianluca Ianiro, Rome, Italy
16.50 – 17.00 10 minutes break
17.00 – 19.00 IX - Symposium: Gastric Cancer – Early detection and prevention 2020
17.00 – 17.20 H. pylori in the stomach – factors contributing to its dominance
Richard Peek, Nashville, TN, USA
17.20 – 17.40 Current epidemiology and gastric cancer patterns
Constanza Camargo, Rockville, USA
17.40 – 18.00 Population-based screening of gastric cancer
Jin-Young Park, Lyon, France
18.00 – 18.30 H. pylori screen-and-treat: Pro & Con - Talk
18.00 – 18.15 Con: Anthony O'Connor, Dublin, Ireland
18.15 – 18.30 Pro: Jan Bornschein, Oxford, UK
18.30 – 19.00 Preneoplastic conditions - Tandem Talk
18.30 – 18.45 is it time for molecular risk prediction? Marnix Jansen, London, UK
18.45 – 19.00 how good is endoscopy? Alexander Link, Magdeburg, Germany
19.00 – 19.15 X - Closing Session
19.00 – 19.10 Poster Awards
19.10 – 19.15 Presentation of the EHMSG Workshop 2021 in Belgrade
Mirjana Rajilic-Stojanovic, Belgrade, Serbia